Good morning – Below I’ve provided a link to the August 20th interview with Dr. Kennen MacKay, Managing Director and Co-Head of Biotechnology Research for RBC Capital Markets and Janet Engels, Head of the U.S. Portfolio Advisory Group, wherein they discuss the current situation with COVID-19. Dr. MacKay zeros in on the data re: the number of cases, speaks about how close we are to a vaccine and the impact of the race to find effective treatments, now and into the future.

Janet asks the question on all of our minds - “When do we get back to normal?”

Listen here (approx. 20-minute duration).

Thanks,

Libby

 

 

The information contained herein has been obtained from sources believed to be reliable at the time obtained but neither RBC Dominion Securities Inc.* nor its employees, agents, or information suppliers can guarantee its accuracy or completeness. This report is not and under no circumstances is to be construed as an offer to sell or the solicitation of an offer to buy any securities. This report is furnished on the basis and understanding that neither RBC Dominion Securities Inc. nor its employees, agents, or information suppliers is to be under any responsibility or liability whatsoever in respect thereof. The inventories of RBC Dominion Securities Inc. may from time to time include securities mentioned herein. RBC Dominion Securities Inc. and Royal Bank of Canada are separate corporate entities which are affiliated. *Member CIPF. ®Registered trademark of Royal Bank of Canada. Used under licence. ©Copyright 2004. All rights reserved.